1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma who were treated beyond progression in a randomized phase 2 dose-ranging trial
    Meeting Abstract

    George, S.; Motzer, R. J.; Hammers, H.; Redman, B.; Kuzel, T.; Tykodi, S. S.; Plimack, E.; Jiang, J.; Waxman, I.; Rini, B. I.
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Presence of AR-V7 splice variant or AR C terminal loss in the CTCs of mCRPC patients identifies patients with improved PSA response with taxanes over androgen receptor signaling directed therapies (ARS Rx)
    Meeting Abstract

    Scher, H. I.; Kelvin, J.; Lu, D.; Louw, J.; Packer, D.; Bambury, R.; Rathkopf, D.; Schreiber, N.; Brennan, R.; Prigozhina, N.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Correlative analyses of serum biomarkers and clinical outcomes in the phase 2 study of lenvatinib, everolimus, and the combination, in patients with metastatic renal cell carcinoma following 1 VEGF-targeted therapy
    Meeting Abstract

    Glen, H.; Hsieh, J.; Michaelson, M. D.; Kim, H. J.; Sachdev, P.; Kadowaki, T.; Funahashi, Y.; Larkin, J.; Motzer, R.
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Phase I study of investigational oral mTORC1/2 inhibitor MLN0128: Expansion phase in patients with renal, endometrial, or bladder cancer
    Meeting Abstract

    Voss, M.; Gordon, M. S.; Mita, M.; Rini, B.; Makker, V.; Macarulla, T.; Smith, D.; Kwak, E. L.; Cervantes, A.; Puzanov, I.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Role of cap-dependent translation in response to upstream kinase-targeted therapy in colorectal cancer
    Meeting Abstract

    Ye, Q.; Cai, W. J.; Evers, B. M.; Solit, D.; Rosen, N.; She, Q. B.
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save
  • PBRM1: A critical subunit of the SWI/SNF chromatin remodeling complex
    Book Section

    Lee, C. H.; Pham, C. G.; Hsieh, J. J.
    In Bukowski, R. M.; Figlin, R. A.; Motzer, R. J. (Eds.) Renal Cell Carcinoma: Molecular Targets and Clinical Applications. 3rd ed (2015)

    Fulltext@MSK | Save
  • Renal cell carcinoma: Molecular targets and clinical applications. 3rd ed
    Book Whole


    Springer New York (2015)

    Fulltext@MSK | Save
  • Targeted therapy for metastatic renal cell carcinoma: Introduction
    Book Section

    Bukowski, R. M.; Figlin, R. A.; Motzer, R. J.
    In Bukowski, R. M.; Figlin, R. A.; Motzer, R. J. (Eds.) Renal Cell Carcinoma: Molecular Targets and Clinical Applications. 3rd ed (2015)

    Fulltext@MSK | Save
  • Development and validation of a prognostic nomogram for progression-free survival in patients with advanced renal cell carcinoma treated with pazopanib
    Journal Article

    Kattan, M. W.; Sternberg, C. N.; Mehmud, F.; Bhatt, K.; McCann, L.; Motzer, R. J.
    Oncology (2015)

    Fulltext@MSK | Save
  • Alternative transcription initiation leads to expression of a novel ALK isoform in cancer
    Journal Article

    Wiesner, T.; Lee, W.; Obenauf, A. C.; Ran, L.; Murali, R.; Zhang, Q.; Wong, E. W. P.; Hu, W.; Scott, S. N.; Shah, R. H.; more...
    Nature (2015)

    Fulltext@MSK | Save